International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Proniosomal Gel: A novel drug delivery

Shivani Fotedar, Anshul Namdev, Sakshi Singh Chouhan, Madhuri Sharma, Priyanka Gupta, Dr. Arun K Gupta

Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India

Article Information

Volume / Issue3 / 2 (April-June 2022)
Pages39-41
AccessOpen Access

Publication Timeline

  • Received05 May 2022
  • Accepted22 May 2022

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Different types of drug delivery systems are intended to deliver therapeutic agents to the appropriate site of interest to get desired pharmacological effect. In the field of drug delivery, the advancement of nanotechnology helps to develop novel dosage forms like proniosomes. They are dry formulation of water-soluble carrier particles that are coated with surfactant. They are rehydrated to form niosomal dispersion immediately before use on agitation in hot aqueous media within minutes. Proniosomes are physically stable during the storage and transport. Drug encapsulated in the vesicular structure of proniosomes prolong the existence of drug in the systematic circulation and enhances the penetration into target tissue and reduce toxicity. This article reviews provesicular drug delivery systems with a focus on composition, preparation, the mechanism of drug delivery, encapsulation of the drug into provesicles and characterization techniques.

Keywords

Provesiclesproniosomesnovel drug deliverynon-ionic surfactanttransdermal drug deliverytoxicity

References

  1. Kakr R, Rao R, Goswami A, Nanda S, Saroha K. Proniosomes: An emerging vesicular system in drug delivery and cosmetics. Der Pharmacia Lettre. 2010; 2:227-39 [Google Scholar][Crossref]
  2. Sankar V, Ruckmani K, Durga S, Jailani S. Proniosomes as drug carriers. Pak J Pharm Sci. 2010; 23:103-7. [Google Scholar][Crossref]
  3. Goud BA, Raju J, Rambhau D. Improved oral absorption of carbamazepine from sorbiton monolaurate based proniosome systems containing charged surface ligands. Int J Biol Pharm Res. 2012; 3:37-42. [Google Scholar][Crossref]
  4. Biju SS, Talegaonkar S, Misra PR. Vesicular systems: Anoverview. Indian J Pharm Sci. 2006; 68:141-57. [Google Scholar][Crossref]
  5. Akhilesh D, Hazel G, Kamath JV. Proniosomes: A propitious provesicular drug carrier. Int J Pharm Pharm Sci Res. 2011; 1(3):98-103. [Google Scholar][Crossref]
  6. Kakar R, Rao R, Goswami A, Nanda S, Saroha K. Proniosomes: An emerging vesicular system in drug delivery and cosmetics. Der Pharm Lett. 2010; 2(4):227-39. [Google Scholar][Crossref]
  7. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery: An overview. Acta Pharm Sin. B 2011; 1(4):208-19. [Google Scholar][Crossref]
  8. Jadhav KR, Pawar AY, Bachhav AA. Proniosomes: A novel non-ionic pro-vesicles as potential drug carrier. Asian J Pharm. 2016; 10 (3):S210. [Google Scholar][Crossref]
  9. Azeem A, Jain N, Iqbal Z, Ahmad FJ, Aqil M, Talegaonkar S. Feasibility of proniosomes based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol. 2008; 13(2):155-63. doi: 10.1080/10837450701831211.PMID: 18379906. [Google Scholar][Crossref]
  10. Keservani RK, Sharma AK, Ayaz MD. Novel drug delivery system for the vesicular delivery of drug by the niosomes. Int J Res Control Release. 2011; 1:1-8. [Google Scholar][Crossref]
  11. Chandra A, Sharma PK. Proniosome based drug delivery system of piroxicam. Afr J Pharm Pharmacol. 2008; 2:184-90. [Google Scholar][Crossref]
  12. Azarbayjani AF, Tan EH, Chan YW. In vitro drug release of niosomes prepared from various proniosomal haloperidol by proniosomal formulations with non-ionic surfactants. Biol Pharm Bull. 2009; 32:1453-8. [Google Scholar][Crossref]
  13. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm. 2011; 77(1):43-55. [Google Scholar][Crossref]
  14. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31(3):81-86. [Google Scholar][Crossref]
  15. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002; 244(1-2):73-80. Doi: 10.1016/s0378-5173(02)00301-0. PMID: 12204566. [Google Scholar][Crossref]

How to Cite

Fotedar, S., Namdev, A., Chouhan, S. S., Sharma, M., Gupta, P., & Gupta, A. K. (2022). Proniosomal Gel: A novel drug delivery. International Journal of Medical and All Body Health Research, 3(2), 39-41.

Fotedar, Shivani, et al. "Proniosomal Gel: A novel drug delivery." International Journal of Medical and All Body Health Research, vol. 3, no. 2, 2022, pp. 39-41.

Fotedar, S., Namdev, A., Chouhan, S. S., Sharma, M., Gupta, P. and Gupta, A. K. (2022) 'Proniosomal Gel: A novel drug delivery', International Journal of Medical and All Body Health Research, 3(2), pp. 39-41.

Fotedar S, Namdev A, Chouhan SS, Sharma M, Gupta P, Gupta AK. Proniosomal Gel: A novel drug delivery. International Journal of Medical and All Body Health Research. 2022;3(2):39-41.

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.